Author:
Zhao Yong,Liu Chengke,Zhang Qing,Wang Changzheng,Sun Bin,Zhang Shun,Zhang Bin
Publisher
Springer Science and Business Media LLC
Reference9 articles.
1. Tanaka S, Noguchi N, Ochiai T, et al. Outcomes and recurrence of initially resectable hepatocellular carcinoma meeting milan criteria: rationale for partial hepatectomy as first strategy. J Am Coll Surg, 2007, 204: 1–6.
2. Tang ZY. The focal point of research primary liver cancer: recurrence and metastases. Chin J Hepatobil Surg (Chinese), 1999, 5: 3–5.
3. Qiu YD, Ding YT. Advances in research and treatment of primary liver cancer’s recurrence and metastases. J Hepatobil Surg (Chinese), 2001, 9: 6–7.
4. Wang QX, Yan JJ, Zhou FG, et al. Exploration of indication of prophylactic transcatheter arterial chemoembolization on postoperative recurrence of hepatocellular carcinoma. Chin J Surg (Chinese), 2009, 47: 748–751.
5. Hao MZ, Lin HL, Shen YH, et al. Efficacy of percutaneous ethanol injection in the adjuvant treatment of hepatocellular carcinoma after TACE. Chinese-German J Clin Oncol, 2009, 8: 69–72.